These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. The long-term safety and efficacy of gabapentin (Neurontin) as add-on therapy in drug-resistant partial epilepsy. The US Gabapentin Study Group. Epilepsy Res; 1994 May; 18(1):67-73. PubMed ID: 8088258 [Abstract] [Full Text] [Related]
3. Conversion to high dose gabapentin monotherapy in patients with medically refractory partial epilepsy. Beydoun A, Fakhoury T, Nasreddine W, Abou-Khalil B. Epilepsia; 1998 Feb; 39(2):188-93. PubMed ID: 9577999 [Abstract] [Full Text] [Related]
4. A double-blind trial of gabapentin monotherapy for newly diagnosed partial seizures. International Gabapentin Monotherapy Study Group 945-77. Chadwick DW, Anhut H, Greiner MJ, Alexander J, Murray GH, Garofalo EA, Pierce MW. Neurology; 1998 Nov; 51(5):1282-8. PubMed ID: 9818846 [Abstract] [Full Text] [Related]
5. [Trials with gabapentin monotherapy in patients with complex partial or secondary generalized seizures]. Pierce MW, Shokry A. Praxis (Bern 1994); 1997 Sep 10; 86(37):1430-1. PubMed ID: 9381042 [Abstract] [Full Text] [Related]